DR

Dipikaben Rakeshbhai Soni

Active Director Director DIN 11373381
DIN 11373381 First appointment Nov 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Dipikaben Rakeshbhai Soni

Data last updated:

Dipikaben Rakeshbhai Soni is a Director at Clinitext Solutions Private Limited (since 2025). The company operates in Healthcare.

DIN 11373381
Primary Designation Director
Industry Healthcare
First Appointment 07 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clinitext Solutions Private Limited U86909GJ2025PTC169337
Director07 Nov 20252025Active

Board colleagues of Dipikaben Rakeshbhai Soni

NameDINCompanyDesignation
Jay Bipinchandra Trivedi11373380Clinitext Solutions Private LimitedDirector

Directorship timeline

Open interactive timeline →
Clinitext Solutions Private Limited
Premium access

Shareholding and investment profile for Dipikaben Rakeshbhai Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipikaben Rakeshbhai Soni

Dipikaben Rakeshbhai Soni currently holds 1 directorship: Clinitext Solutions Private Limited (Director, since 07 Nov 2025).

Dipikaben Rakeshbhai Soni was first appointed on 07 Nov 2025 as Director at Clinitext Solutions Private Limited.

The current boards of Dipikaben Rakeshbhai Soni's companies include Jay Bipinchandra Trivedi (Clinitext Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available